세계의 심장 이식 시장 보고서(2025년)
Heart Transplant Global Market Report 2025
상품코드 : 1825404
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

심장 이식 시장의 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.5%로 181억 4,000만 달러로 성장할 전망입니다. 예측기간의 성장은 정부의 지원과 자금 제공, 이식 프로그램의 세계화, 이식 센터의 능력 향상, 원격의료와 원격 모니터링의 통합 등에 기인할 것으로 예상됩니다. 예측기간의 주요 동향은 기술의 진보, 인공심장과 보조장치, 기증자 장기 선택과 인공지능(AI)의 통합 등입니다.

향후 5년간의 예측 성장률 9.5%는 과거 예측에서 0.1% 소폭 감소한 수치입니다. 이러한 성장세 둔화는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 부과로 인해 독일과 벨기에에서 수입되는 장기 관류 시스템 및 면역억제제 비용이 상승하고 수술 후 결과가 악화되거나 순환기과 비용이 상승할 수 있으므로 미국의 이식 프로그램이 지장을 받을 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 예상됩니다.

심혈관질환의 유병률 증가는 앞으로 수년간 심장 이식 시장의 성장을 가속할 것으로 예측됩니다. 심혈관질환에는 심장과 혈관에 영향을 미치는 다양한 질병이 포함됩니다. 심장 이식은 다른 치료법에 반응하지 않는 말기 심부전 환자의 마지막 치료법이며 삶의 질을 크게 개선하고 수명을 연장합니다. 예를 들어, 2024년 9월 영국에 본부를 둔 심혈관 연구 자선단체 영국심장재단은 영국에서 약 760만 명이 심장 및 순환기 질환을 앓고 있으며, 그 내역은 남성 400만 명, 여성 360만 명이라고 보고했습니다. 이 수는 2030년까지 100만명 가량 증가할 것으로 예상되며 2040년까지 200만명 가량 증가할 전망입니다. 따라서 심혈관질환의 유병률 증가가 심장 이식 시장을 견인할 전망입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

A heart transplant is a sophisticated surgical procedure in which a damaged or diseased heart is removed and replaced with a healthy donor heart. This intervention is crucial and can be life-saving for individuals suffering from end-stage heart failure or specific severe heart conditions.

There are several types of heart transplant surgeries, including total artificial heart, biventricular pacing, ventricular assist devices, and other specialized procedures. A total artificial heart is a mechanical device specifically engineered to take over the functions of both the left and right ventricles of the natural human heart. This category encompasses various transplant techniques like autografts, allografts, and others. The primary recipients of these procedures are hospitals, cardiac institutes, and other specialized medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The heart transplant market research report is one of a series of new reports from The Business Research Company that provides heart transplant market statistics, including heart transplant industry global market size, regional shares, competitors with a heart transplant market share, detailed heart transplant market segments, market trends and opportunities and any further data you may need to thrive in the heart transplant industry. This heart transplant market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The heart transplant market size has grown strongly in recent years. It will grow from $11.49 billion in 2024 to $12.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to medical advancements, increased awareness and education, advancements in organ preservation, healthcare infrastructure.

The heart transplant market size is expected to see strong growth in the next few years. It will grow to $18.14 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to government support and funding, globalization of transplant programs, increasing transplant center capacity, integration of telemedicine and remote monitoring. Major trends in the forecast period include technological advancements, artificial heart and assist devices, artificial intelligence (AI) in donor organ selection.

The forecast of 9.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. transplant programs by increasing costs for organ perfusion systems and immunosuppressive drugs imported from Germany and Belgium, potentially compromising post-surgical outcomes and raising cardiology department expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the heart transplant market in the coming years. Cardiovascular diseases encompass a range of conditions that affect the heart and blood vessels. A heart transplant is a treatment of last resort for individuals with end-stage heart failure who have not responded to other therapies. It significantly improves the quality of life and extends life expectancy. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are currently affected by heart and circulatory diseases, including 4 million men and 3.6 million women. This number is expected to increase by 1 million by 2030 and could rise by an additional 2 million by 2040. As a result, the growing prevalence of cardiovascular diseases will drive the heart transplant market.

The heart transplant market is experiencing growth driven by an increased awareness of organ donation and transplantation. This awareness encompasses knowledge, understanding, and community consciousness regarding the processes, significance, and impact of these procedures in healthcare. This heightened awareness is playing a substantial role in the realm of heart transplants, leading to an expanded donor pool, reduced waiting times for recipients, and improved patient outcomes. For instance, in January 2023, the United Network for Organ Sharing, a US-based non-profit organization focused on science and education, reported a record of 42,887 organ transplants in the US in 2022, marking a 3.7% increase from the previous year. This included 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplants, underscoring the impact of this growing awareness. Consequently, the surge in awareness about organ donation and transplantation is a key driver for the heart transplant market.year. This included 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplant. Therefore, the growing awareness about organ donation and transplantation will drive the heart transplant market.

Major companies in the heart transplant market are increasingly focused on developing innovative solutions, such as heart preservation technology, to enhance patient outcomes and improve transplant success rates. This technology significantly extends the preservation time of the heart outside the body compared to traditional ice storage, leading to better outcomes and reduced complications after transplantation. For instance, in May 2023, Xvivo Perfusion AB, a Sweden-based medical technology company, received approval from the U.S. Food and Drug Administration (FDA) for its Investigational Device Exemption (IDE) application for heart preservation technology. This approval enabled the company to launch the "PRESERVE Clinical Trial," a prospective, multicenter, single-arm, open-label study focused on evaluating hearts transplanted after non-ischemic heart preservation from extended donors, including those from Donation after Circulatory Death (DCD). The key feature of Xvivo's heart preservation technology is its non-ischemic hypothermic perfusion system, which uses cold, oxygenated perfusion to preserve donor hearts during transport.

In August 2024, Getinge, a Sweden-based company specializing in medical technology and healthcare solutions, acquired Paragonix Technologies for an undisclosed amount. This acquisition allows Getinge to strengthen its capabilities in organ preservation and transportation, with a focus on improving patient outcomes in transplant procedures. Paragonix Technologies, a U.S.-based company, designs, manufactures, and sells devices used for the transport of organs for transplant.

Major companies operating in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.

North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the heart transplant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The heart transplant market includes revenues earned by entities by providing services such as patient evaluation and selection, waitlist management, donor heart procurement, transplant surgery, immunosuppression management, psychosocial support and complications management services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Heart Transplant Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on heart transplant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for heart transplant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The heart transplant market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Heart Transplant Market Characteristics

3. Heart Transplant Market Trends And Strategies

4. Heart Transplant Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Heart Transplant Growth Analysis And Strategic Analysis Framework

6. Heart Transplant Market Segmentation

7. Heart Transplant Market Regional And Country Analysis

8. Asia-Pacific Heart Transplant Market

9. China Heart Transplant Market

10. India Heart Transplant Market

11. Japan Heart Transplant Market

12. Australia Heart Transplant Market

13. Indonesia Heart Transplant Market

14. South Korea Heart Transplant Market

15. Western Europe Heart Transplant Market

16. UK Heart Transplant Market

17. Germany Heart Transplant Market

18. France Heart Transplant Market

19. Italy Heart Transplant Market

20. Spain Heart Transplant Market

21. Eastern Europe Heart Transplant Market

22. Russia Heart Transplant Market

23. North America Heart Transplant Market

24. USA Heart Transplant Market

25. Canada Heart Transplant Market

26. South America Heart Transplant Market

27. Brazil Heart Transplant Market

28. Middle East Heart Transplant Market

29. Africa Heart Transplant Market

30. Heart Transplant Market Competitive Landscape And Company Profiles

31. Heart Transplant Market Other Major And Innovative Companies

32. Global Heart Transplant Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Heart Transplant Market

34. Recent Developments In The Heart Transplant Market

35. Heart Transplant Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기